Asset Class in Focus

Ten years after the global financial crisis of 2008, FSA notes that pharmaceutical, healthcare and biotech stocks weathered that year better than other sectors.

Asset Class in Focus

Riding China’s policy bus is not as easy as it sounds, as the poor performance of China policy-driven funds shows.

Asset Class in Focus

Part two of a look at the hype surrounding the ESG theme finds that there are sound reasons to be skeptical about claims that ESG investments outperform the general market.